Cervical Device Contraception-2 (Nanopaz) (NANOPAZ)
Recruitment status was Not yet recruiting
Measure blood progesterone by using cervical device contraception.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Cervical Device Contraception|
- blood progesterone measure in blood [ Time Frame: one to two months ] [ Designated as safety issue: Yes ]
|Study Start Date:||June 2008|
|Estimated Study Completion Date:||May 2010|
|Estimated Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Other: Nanopaz contraception device
A very small cervical device that releases small amount of progesterone 20 mcgm/day.
The target of the research is to measure blood progesterone by using the cervical device.
This small device delivers progesterone by nanotechnology method.